Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Swierczek

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Experimental Hematology|February 3, 2020
Clonal hematopoiesis in hematological disorders: Three different scenariosSabina Swierczek, Josef T Prchal
Current Hematologic Malignancy Reports|October 14, 2017
Familial MPN PredispositionTsewang Tashi, Sabina Swierczek, Josef T Prchal
Discovery Medicine|July 29, 2011
Convergent mechanisms of somatic mutations in polycythemia veraKai Wang, Sabina Swierczek, Kimberly Hickman, et al.
Blood Cells, Molecules & Diseases|March 7, 2009
Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturationHana Bruchova, Donghoon Yoon, Archana M Agarwal, et al.
The Journal of Biological Chemistry|July 11, 2006
Zinc metalloregulation of the zinc finger pair domainAmanda J Bird, Sabina Swierczek, Wei Qiao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Thrombotic Thrombocytopenic Purpura Associated With Pegylated Interferon Alfa-2a Use in a Patient With Polycythemia VeraRadhika Gangaraju, Soo J Kim, Jing-Fei Dong, et al.
Experimental Hematology & Oncology|October 7, 2016
Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with <i>JAK2</i><sup>V617F</sup> allelic burdenMagdalena Kovacsovics-Bankowski, Todd W Kelley, Olga Efimova, et al.
Pediatric Blood & Cancer|April 15, 2014
The homozygous VHL(D126N) missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertensionSusmita Sarangi, Lucie Lanikova, Katarina Kapralova, et al.
Blood|September 21, 2016
Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia veraLucie Lanikova, Olga Babosova, Sabina Swierczek, et al.
Molecular Microbiology|July 28, 2005
Zap1 activation domain 1 and its role in controlling gene expression in response to cellular zinc statusAndrew Herbig, Amanda J Bird, Sabina Swierczek, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Experimental Hematology|February 3, 2020
Clonal hematopoiesis in hematological disorders: Three different scenariosSabina Swierczek, Josef T Prchal
Current Hematologic Malignancy Reports|October 14, 2017
Familial MPN PredispositionTsewang Tashi, Sabina Swierczek, Josef T Prchal
Discovery Medicine|July 29, 2011
Convergent mechanisms of somatic mutations in polycythemia veraKai Wang, Sabina Swierczek, Kimberly Hickman, et al.
Blood Cells, Molecules & Diseases|March 7, 2009
Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturationHana Bruchova, Donghoon Yoon, Archana M Agarwal, et al.
The Journal of Biological Chemistry|July 11, 2006
Zinc metalloregulation of the zinc finger pair domainAmanda J Bird, Sabina Swierczek, Wei Qiao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Thrombotic Thrombocytopenic Purpura Associated With Pegylated Interferon Alfa-2a Use in a Patient With Polycythemia VeraRadhika Gangaraju, Soo J Kim, Jing-Fei Dong, et al.
Experimental Hematology & Oncology|October 7, 2016
Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with <i>JAK2</i><sup>V617F</sup> allelic burdenMagdalena Kovacsovics-Bankowski, Todd W Kelley, Olga Efimova, et al.
Pediatric Blood & Cancer|April 15, 2014
The homozygous VHL(D126N) missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertensionSusmita Sarangi, Lucie Lanikova, Katarina Kapralova, et al.
Blood|September 21, 2016
Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia veraLucie Lanikova, Olga Babosova, Sabina Swierczek, et al.
Molecular Microbiology|July 28, 2005
Zap1 activation domain 1 and its role in controlling gene expression in response to cellular zinc statusAndrew Herbig, Amanda J Bird, Sabina Swierczek, et al.
Pageof 3